(3S)-3-ETHYLPYRROLIDINE HCL, 95.0%, 100mg

(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)methanol, 95.0%, 1g

[5-(4-methoxyphenyl)isoxazol-3-yl]acetic acid, 95.0%, 500mg

Orotic acid monohydrate, min. 99%, 250 g, plastic packaging.

1-Pyridin-2-yl-ethylamine oxalate, 90.0%, 1g

4-Bromo-N-(4-cyanophenyl)benzenesulfonamide, 95%, 100mg

Methyl 4-Bromo-1H-pyrrole-2-carboxylate, 97.0%, 5g

[4-(methoxycarbonyl)thiophen-2-yl]boronic acid, 98%, 1g

2-Cyclopentyl-2-phenylethan-1-amine, 95+%, 2.5g

4-Chloro-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine, 95%, 250mg

N-cyclohexyl-2-naphthamide, 98%, 5g

1-(2-Methylphenyl)-2,3-butadien-1-one, 250mg

2-Bromobenzamide, 98.0%, 25g